Sodium Oxybate

CAS 502-85-2 7 current recordsSmall Molecule

Who holds supplier records for Sodium Oxybate? 7 organisations hold a current record for Sodium Oxybate: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (3), United States (2) and United Kingdom (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Sodium Oxybate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/sodium-oxybate

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 3 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Sodium Oxybate expires 16 Mar 2042. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Sodium Oxybate. Country is the organisation's recorded country, not necessarily the manufacturing site.

India3United States2United Kingdom1Country not recorded for 1
Need Sodium Oxybate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (7 listed products contain Sodium Oxybate). The latest listed patent expires 16 Mar 2042. The latest listed exclusivity runs to 16 Oct 2031. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Sodium Oxybate is the sodium salt of gamma-hydroxybutyric acid (GHB), used therapeutically for the treatment of narcolepsy with cataplexy and excessive daytime sleepiness. It acts as a central nervous system depressant modulating GABA receptors in the brain.

Chemical identity

IUPAC name
4-hydroxybutanoate
Canonical SMILES
C(CC(=O)[O-])CO
InChIKey
SJZRECIVHVDYJC-UHFFFAOYSA-M
Synonyms
Xyrem API, 4-Hydroxybutanoate, 4-hydroxybutyrate, Hydroxybutyrate, g-hydroxybutyric acid, CHEBI:16724, Butyric acid, hydroxy-, ion(1-), Butanoic acid, hydroxy-, ion(1-), RefChem:524018, Butyric acid, hydroxy, ion(1), Butanoic acid, hydroxy, ion(1), Gamma Hydroxy butyrate

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Central Nervous System Depressant
Physiologic effect
Central Nervous System Depression; Decreased Central Nervous System Organized Electrical Activity

Therapeutic areas

NarcolepsyCataplexySleep Disorders

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Sodium Oxybate?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Sodium Oxybate: Alkem Laboratories Limited (India), CAMBREX CHARLES CITY INC (United States), CHATTEM CHEMICALS INC (United States), CURIA MISSOURI INC, Granules India Limited (India), Intas Pharmaceuticals Ltd. (India) and VERANOVA LP (United Kingdom). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Sodium Oxybate Drug Master Files are active?

Alkem Laboratories Limited (DMF 28289), CAMBREX CHARLES CITY INC (DMF 35870), CHATTEM CHEMICALS INC (DMF 40348), CURIA MISSOURI INC (DMF 27599), Granules India Limited (DMF 39696), Intas Pharmaceuticals Ltd. (DMF 44484) and VERANOVA LP (DMF 24049). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

Does the FDA Orange Book list patents for products containing Sodium Oxybate?

Yes. The latest patent listed for an approved US product containing Sodium Oxybate expires 16 Mar 2042, across 7 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Sodium Oxybate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Sodium Oxybate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.